Literature DB >> 23377504

Is dexmedetomidine or remifentanil alone an optimal sedation scheme for awake intubation?

Jia Qiang Zhang, Fan Min Meng, Fu Shan Xue.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23377504     DOI: 10.1007/s00540-013-1560-5

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


× No keyword cloud information.
  4 in total

1.  Dexmedetomidine versus remifentanil sedation during awake fiberoptic nasotracheal intubation: a double-blinded randomized controlled trial.

Authors:  Rong Hu; J X Liu; Hong Jiang
Journal:  J Anesth       Date:  2012-10-17       Impact factor: 2.078

2.  Median effective dose of remifentanil for awake laryngoscopy and intubation.

Authors:  Ya-chao Xu; Fu-shan Xue; Mao-ping Luo; Quan-yong Yang; Xu Liao; Yi Liu; Yan-ming Zhang
Journal:  Chin Med J (Engl)       Date:  2009-07-05       Impact factor: 2.628

3.  Awake nasotracheal fiberoptic intubation: patient comfort, intubating conditions, and hemodynamic stability during conscious sedation with remifentanil.

Authors:  Anette-Marie Machata; Christopher Gonano; Andrea Holzer; Dorothea Andel; Christian K Spiss; Michael Zimpfer; Udo M Illievich
Journal:  Anesth Analg       Date:  2003-09       Impact factor: 5.108

4.  Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate.

Authors:  J P Belleville; D S Ward; B C Bloor; M Maze
Journal:  Anesthesiology       Date:  1992-12       Impact factor: 7.892

  4 in total
  1 in total

1.  Using Lean tools to improve the efficiency of awake fibreoptic intubation setup.

Authors:  Wade A Weigel; Andrew B Lyons; Justin S Liberman; C Craig Blackmore
Journal:  BMJ Open Qual       Date:  2021-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.